A patient recently sat across from me, phone in hand, scrolling through months of heart rate variability (HRV) data. He wasn’t asking me to interpret a lab value or an MRI. In a sense, he was asking me to interpret himself, filtered through an algorithm he strongly trusted, one that would not be contradicted by medical advice or even his own body.
He’s 58, a recreational cyclist, motivated and well-read. He was also, as I have increasingly seen in my practice, wearing a device that promised to tell him exactly how he was recovering each morning. His question wasn’t really about heart rate variability. It was the same question athletes have asked coaches for generations, just dressed up in new language: How do I know if I’m actually breaking down, or just making excuses not to push hard?
As an interventional physiatrist and a competitive masters physique athlete myself, I’ve spent time on both sides of that question. It’s worth examining what the evidence supports, because the gap between what these devices measure and what patients believe they’re telling them is where I increasingly find myself doing the real clinical work.
Heart rate variability reflects the interplay between the sympathetic and parasympathetic branches of the autonomic nervous system, specifically the beat-to-beat variation that occurs as the vagus nerve actively modulates heart rate. It is not a fringe metric. Reduced HRV has a robust evidence base as a marker of accumulated physiological stress, and HRV-guided training protocols have outperformed fixed-load programs in recreational athlete populations, improving markers such as VO2max while reducing overtraining symptoms.
Real physician voices, twice a week
Free, and one click to unsubscribe.
Consumer devices have also gotten better at capturing it. Recent validation work comparing wrist-worn wearables with polysomnography, the clinical gold standard for sleep staging, found agreement rates in the 85-90 percent range for total sleep time and sleep stage classification. That’s a meaningful improvement over the notoriously unreliable early generation of sleep trackers, and it’s part of why patients now bring this data into the exam room with real confidence.
Therefore, the skepticism I am raising isn’t about whether HRV is measuring something physiologically meaningful. It is. The problem is that there might be a disconnect between the measurement and the presumed meaning.
A 2026 perspective piece on wearable data in orthopedic care made an observation that struck me because I see it clinically every week: Consumer-grade wearables now generate validated, clinically relevant physiologic data, but the clinical infrastructure to interpret and act on that data hasn’t caught up. Physicians aren’t trained to read a patient’s six-month HRV trend the way we’re trained to read a chest X-ray. Standardized interpretation thresholds largely don’t exist outside sports science research settings, a point echoed in a 2026 narrative review on HRV monitoring via mobile devices.
This gap matters even more in older recreational athletes for reasons the research on younger elite populations doesn’t fully capture. Resting HRV naturally declines over the decades, independent of fitness or training status. A 58-year-old’s “suppressed” reading may be his physiologic baseline, not a signal of overtraining, a distinction his device isn’t equipped to make, and he isn’t equipped to know without a clinician contextualizing it.
In a 25-year-old, a persistently low HRV is usually due to one of two things: training stress or poor sleep. In a patient in his 50s or 60s, that same number sits inside a much broader differential: early cardiovascular disease, medication effects, sleep apnea, thyroid dysfunction, or the autonomic effects of chronic pain conditions. Treating a wearable number as a training instruction, without a clinician ruling out these risks, may lead to both overtraining an athlete who’s actually developing a medical problem and under-training one who’s simply misreading noise as signal.
One point that deserves far more attention than it gets: HRV suppression and overtraining syndrome are deeply intertwined with low energy availability, particularly in athletes who train hard and diet aggressively, a combination I see often in motivated patients over 50 trying to hold onto muscle mass while managing weight. Reduced HRV in older adults is not always due to training or nutrition alone; common medical causes in this group include cardiovascular disease, effects of antihypertensive or beta-blocker medications, type 2 diabetes, sleep apnea, thyroid dysfunction, and the autonomic effects of chronic pain conditions. A wearable will flag the suppressed HRV. It will not tell a patient that the actual problem is under-fueling rather than overtraining, or alert them to these broader differential diagnoses, a distinction only a clinician can make. Adding rest days without addressing caloric intake, for example, won’t resolve under-fueling. This is consistent with broader findings on HRV’s clinical application in strength and conditioning, which caution that reduced HRV alone is not always a sensitive or specific marker of overtraining.
I use HRV in my own training. I trend it rather than react to any single morning’s number, because one low reading is noise and a week-long pattern is signal. That distinction, trend over single point, is the single most useful thing I’ve learned from both the literature and my own decade-plus of tracking it through competition prep.
But I don’t let the device make the diagnosis. When a patient brings me a chart of declining HRV, my first questions aren’t about their training program. They’re about sleep, stress, medications, and whether we’ve ruled out something the algorithm can’t see. The number is a starting point for a clinical conversation, not a substitute for one.
We are not going to put this technology back in the box, nor should we want to. It has genuinely made my patients more attuned to their own physiology, and it’s given me a longitudinal window into recovery that I didn’t have access to a decade ago. But there’s a real difference between a tool that generates data and one that generates understanding, and right now the burden of closing that gap falls almost entirely on physicians, who often haven’t been trained to do so.
That, to me, is the actual opportunity: not dismissing wearable data, and not accepting it uncritically, but building the clinical fluency to sit across from a patient, or look at my own numbers, and know the difference between a body that’s adapting and a body that’s asking for help.
Francisco M. Torres is an interventional physiatrist specializing in diagnosing and treating patients with spine-related pain syndromes. He is certified by the American Board of Physical Medicine and Rehabilitation and the American Board of Pain Medicine and can be reached at Florida Spine Institute and Wellness.
Dr. Torres was born in Spain and grew up in Puerto Rico. He graduated from the University of Puerto Rico School of Medicine. Dr. Torres performed his physical medicine and rehabilitation residency at the Veterans Administration Hospital in San Juan before completing a musculoskeletal fellowship at Louisiana State University Medical Center in New Orleans. He served three years as a clinical instructor of medicine and assistant professor at LSU before joining Florida Spine Institute in Clearwater, Florida, where he is the medical director of the Wellness Program.
Dr. Torres is an interventional physiatrist specializing in diagnosing and treating patients with spine-related pain syndromes. He is certified by the American Board of Physical Medicine and Rehabilitation and the American Board of Pain Medicine. He is a prolific writer and primarily interested in preventative medicine. He works with all of his patients to promote overall wellness.
